DAHIANNA VELEZ: Open Payments
NPI 1649993619 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 9 payments from 7 companies in 2025. Trend: 2023 $79 · 2024 $204 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $100 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| 180 Medical, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $17 |
| Integra LifeSciences Corporation | 1 | $14 |
Products named: GEMTESA, DATROWAY, DARZALEX, PLUVICTO, GENTLECATH GLIDE, NIKTIMVO, TCC-EZ.
Industry payments across FL — which companies pay providers there.
